The assay's ability to predict progression-free survival (PFS) was assessed by comparing the association when the assayed therapy matches the administered therapy (match) with the association when the assayed therapy is randomly selected, not necessarily matching the administered therapy (mismatch).
On the other hand, the fact that treatment satisfaction is associated with increased patient adherence to therapy and to a greater patient desire to continue using the drug may help predict treatment compliance and improve effectiveness of the administered therapy [ 31, 32], with closer follow-up of those patients expected to adhere less to treatment.
If not previously obtained, clinicians could consider obtaining a noncontrast chest computed tomography scan before administering therapy to any patient with a history of bronchiectasis or other architectural lung disease, chronic unexplained cough, or abnormalities noted on their screening chest radiograph suggestive of NTM disease (e.g., reticulonodular infiltrate).
A systematic review which compared self-administered therapy with DOT concluded that DOT did not improve the outcomes [ 35].
Available web-based delivery formats for mental health programs include self-help websites, structured computer-administered therapy with or without computer-generated feedback, and therapies involving asynchronous and synchronous text-based contact with other users (internet support groups) or with therapists [ 25, 26, 28, 30- 32].
MRSA carriers were placed on contact precautions (gown and gloves during patient contact), administered decolonisation therapy with twice daily intranasal mupirocin and daily chlorhexidine washes for 5 days and perioperative prophylaxis was modified to reflect MRSA carriage.
These competitors were HMG-Co A reductase inhibitors (atorvastatin, pravastatin, lovastatin, and simvastatin), and various drugs that are administered in combined therapy with ROS.
The specificity of the antibody was determined by carrying out the competitive assay using dexamethasone that is administered in combined therapy with LND [38], as a competitor.
The possibility of increased administered activity in therapy with 177Lu-DOTATATE is often limited by concern about toxicity resulting from radiation damage to healthy organs (mainly the bone marrow and kidneys) [4, 10 14].
In the control group, we administered only medication therapy with fluconazole (2 mg/mL), once per day and natamycin (2.5 mg/mL) twice per day.
